1	Protection	Protection	B-NP	NN	O	0	ROOT	0
2	from	from	B-PP	IN	O	1	NMOD	-1
3	experimental	experimental	B-NP	JJ	O	6	NMOD	-1
4	ocular	ocular	I-NP	JJ	O	6	NMOD	-1
5	herpetic	herpetic	I-NP	JJ	O	6	NMOD	-1
6	keratitis	keratitis	I-NP	NN	O	2	PMOD	-1
7	by	by	B-PP	IN	O	1	NMOD	-1
8	a	a	B-NP	DT	O	11	NMOD	-1
9	heat-killed	heat-killed	I-NP	JJ	O	11	NMOD	-1
10	virus	virus	I-NP	NN	O	11	NMOD	-1
11	vaccine	vaccine	I-NP	NN	O	7	PMOD	-1
12	.	.	O	.	O	1	P	-1

1	New	New	B-NP	NNP	O	4	NMOD	-1
2	Zealand	Zealand	I-NP	NNP	O	4	NMOD	-1
3	white	white	I-NP	JJ	O	4	NMOD	-1
4	rabbits	rabbit	I-NP	NNS	O	5	SUB	-1
5	were	be	B-VP	VBD	O	0	ROOT	-1
6	given	give	I-VP	VBN	O	5	VC	0
7	limbal	limbal	B-NP	JJ	O	8	NMOD	-1
8	inoculations	inoculation	I-NP	NNS	O	6	OBJ	19	inoculations
9	of	of	B-PP	IN	O	8	NMOD	-1
10	a	a	B-NP	DT	O	12	NMOD	-1
11	heat-killed	heat-killed	I-NP	JJ	O	12	NMOD	-1
12	suspension	suspension	I-NP	NN	O	9	PMOD	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	herpes	herpes	B-NP	NN	O	16	NMOD	-1
15	simplex	simplex	I-NP	NN	O	16	NMOD	-1
16	virus	virus	I-NP	NN	O	13	PMOD	-1
17	(	(	O	(	O	19	DEP	-1
18	HSV	HSV	B-NP	NN	O	19	DEP	-1
19	)	)	O	)	O	16	NMOD	-1
20	in	in	B-PP	IN	O	6	VMOD	-1
21	a	a	B-NP	DT	O	22	NMOD	-1
22	lysate	lysate	I-NP	NN	O	20	PMOD	-1
23	of	of	B-PP	IN	O	22	NMOD	-1
24	human	human	B-NP	JJ	B-cell_type	27	NMOD	-1
25	embryonic	embryonic	I-NP	JJ	I-cell_type	27	NMOD	-1
26	kidney	kidney	I-NP	NN	I-cell_type	27	NMOD	-1
27	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	-1
28	.	.	O	.	O	5	P	-1

1	At	At	B-PP	IN	O	11	VMOD	-1
2	intervals	interval	B-NP	NNS	O	1	PMOD	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	four	four	B-NP	CD	O	6	AMOD	-1
5	to	to	I-NP	TO	O	6	AMOD	-1
6	14	14	I-NP	CD	O	7	NMOD	-1
7	days	day	I-NP	NNS	O	3	PMOD	-1
8	,	,	O	,	O	11	P	-1
9	the	the	B-NP	DT	O	10	NMOD	-1
10	animals	animal	I-NP	NNS	O	11	SUB	-1
11	were	be	B-VP	VBD	O	0	ROOT	-1
12	challenged	challenge	I-VP	VBN	O	11	VC	-1
13	by	by	B-PP	IN	O	12	VMOD	-1
14	intrastromal	intrastromal	B-NP	JJ	O	15	NMOD	-1
15	inoculation	inoculation	I-NP	NN	O	13	PMOD	19	inoculation
16	with	with	B-PP	IN	O	15	NMOD	-1
17	10	10	B-NP	CD	O	21	NMOD	-1
18	,	,	I-NP	,	O	21	P	-1
19	000	000	I-NP	CD	O	21	NMOD	-1
20	plaque-forming	plaque-forming	I-NP	JJ	O	21	NMOD	-1
21	units	unit	I-NP	NNS	O	16	PMOD	-1
22	of	of	B-PP	IN	O	21	NMOD	-1
23	viable	viable	B-NP	JJ	O	24	NMOD	-1
24	HSV	HSV	I-NP	NN	O	22	PMOD	-1
25	.	.	O	.	O	11	P	-1

1	Epithelial	Epithelial	B-NP	JJ	O	2	NMOD	-1
2	keratitis	keratitis	I-NP	NN	O	9	NMOD	-1
3	,	,	O	,	O	9	P	-1
4	disciform	disciform	B-NP	NN	O	5	NMOD	-1
5	edema	edema	I-NP	NN	O	9	NMOD	-1
6	,	,	O	,	O	9	P	-1
7	and	and	O	CC	O	9	NMOD	-1
8	necrotizing	necrotize	B-VP	VBG	O	9	NMOD	-1
9	keratitis	keratitis	B-NP	NN	O	0	ROOT	-1
10	with	with	B-PP	IN	O	9	NMOD	-1
11	neovascularization	neovascularization	B-NP	NN	O	10	PMOD	3	neovascularization
12	of	of	B-PP	IN	O	11	NMOD	-1
13	the	the	B-NP	DT	O	14	NMOD	-1
14	cornea	cornea	I-NP	NN	O	12	PMOD	-1
15	developed	develop	B-VP	VBN	O	14	NMOD	2	developed
16	in	in	B-PP	IN	O	15	VMOD	-1
17	control	control	B-NP	NN	O	18	NMOD	0
18	animals	animal	I-NP	NNS	O	16	PMOD	-1
19	.	.	O	.	O	9	P	-1

1	Epithelial	Epithelial	B-NP	JJ	O	2	NMOD	-1
2	keratitis	keratitis	I-NP	NN	O	5	NMOD	-1
3	and	and	O	CC	O	5	NMOD	-1
4	corneal	corneal	B-NP	JJ	O	5	NMOD	-1
5	edema	edema	I-NP	NN	O	7	SUB	-1
6	also	also	B-ADVP	RB	O	7	VMOD	-1
7	developed	develop	B-VP	VBD	O	24	VMOD	2	developed
8	in	in	B-PP	IN	O	7	VMOD	-1
9	the	the	B-NP	DT	O	11	NMOD	-1
10	immunized	immunize	I-NP	VBN	O	11	NMOD	-1
11	animals	animal	I-NP	NNS	O	8	PMOD	-1
12	during	during	B-PP	IN	O	7	VMOD	-1
13	the	the	B-NP	DT	O	15	NMOD	-1
14	first	first	I-NP	JJ	O	15	NMOD	-1
15	week	week	I-NP	NN	O	12	PMOD	-1
16	after	after	B-PP	IN	O	7	VMOD	-1
17	virus	virus	B-NP	NN	O	18	NMOD	-1
18	challenge	challenge	I-NP	NN	O	16	PMOD	-1
19	,	,	O	,	O	24	P	-1
20	but	but	O	CC	O	24	VMOD	-1
21	these	these	B-NP	DT	O	22	NMOD	-1
22	symptoms	symptom	I-NP	NNS	O	24	SUB	-1
23	rapidly	rapidly	B-ADVP	RB	O	24	VMOD	-1
24	resolved	resolve	B-VP	VBD	O	0	ROOT	-1
25	during	during	B-PP	IN	O	24	VMOD	-1
26	the	the	B-NP	DT	O	28	NMOD	-1
27	following	follow	I-NP	VBG	O	28	NMOD	-1
28	weeks	week	I-NP	NNS	O	25	PMOD	-1
29	.	.	O	.	O	24	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	absence	absence	I-NP	NN	O	18	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	iritis	iritis	B-NP	NN	O	10	NMOD	-1
5	,	,	O	,	O	10	P	-1
6	neovascularization	neovascularization	B-NP	NN	O	10	NMOD	3	neovascularization
7	,	,	O	,	O	10	P	-1
8	and	and	O	CC	O	10	NMOD	-1
9	necrotizing	necrotize	B-VP	VBG	O	10	NMOD	-1
10	keratitis	keratitis	B-NP	NN	O	3	PMOD	-1
11	in	in	B-PP	IN	O	10	NMOD	-1
12	the	the	B-NP	DT	O	13	NMOD	-1
13	corneas	corneas	I-NP	NN	O	11	PMOD	-1
14	of	of	B-PP	IN	O	13	NMOD	-1
15	the	the	B-NP	DT	O	17	NMOD	-1
16	immunized	immunize	I-NP	VBN	O	17	NMOD	-1
17	animals	animal	I-NP	NNS	O	14	PMOD	-1
18	was	be	B-VP	VBD	O	0	ROOT	-1
19	particularly	particularly	B-ADJP	RB	O	20	AMOD	-1
20	striking	striking	I-ADJP	JJ	O	18	PRD	-1
21	.	.	O	.	O	18	P	-1

